11 results
COVID-19 on Lung POCUS - Day 2

Day 2 after COVID diagnosis. Less sore throat, cough &
COVID-19 on Lung ... diagnosis. ... #clinical #lung ... #ultrasound #pulmonary ... #BLines #POCUS
COVID19 vs CHF on POCUS

Spot the difference. 2 pts presenting with nearly same symptoms. Left COVID
COVID19 vs CHF on ... POCUS Spot the ... , right CHF. ... ) #COVID19 #POCUS ... #Clinical #Lung
Day 10 after COVID diagnosis. Less tired, but more cough, ageusia & anosmia. No dyspnea or
Day 10 after COVID ... diagnosis. ... #clinical #lung ... #ultrasound #pulmonary ... #BLines #POCUS
COVID-19 on Lung POCUS

Day 4 after COVID diagnosis. More cough & tiredness (very badly), still no
COVID-19 on Lung ... after COVID diagnosis ... #clinical #lung ... #ultrasound #pulmonary ... #BLines #POCUS
COVID-19 - Subpleural Consolidations on Lung POCUS

Doing daily POCUS LUS for ICU COVID-19 patients in Singapore
Consolidations on Lung ... and density of B lines ... Helps with management ... #clinical #lung ... #ultrasound #pulmonary
Lung POCUS: Small right anechoic parapneumonic effusion. Note B-lines. Curvilinear probe used. More commonly seen in
Lung POCUS: Small ... Note B-lines. ... of COVID19 out ... #POCUS #Pulmonary ... #Ultrasound #Clinical
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Fraction (HFrEF) Clinical ... : weight gain, lung ... HFrEF may lack lung ... #management #cardiology ... #pharmacology #
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
like illnesses, COVID ... Guillain-Barre Clinical ... • Weakness: Starts ... #management #treatment ... #neurology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... edema (“B-lines ... #algorithm #management ... #heartfailure #chf ... #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... , INC risk PE, Pulmonary ... MALT Lymphoma • Lung ... lubricants • Pharmacologic ... #Management